(Q33399073)

English

Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker

scientific article

Statements

Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker (English)
M Catherine Pietanza
Christopher G Azzoli

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit